Document Detail


Hepatitis A among persons with hemophilia who received clotting factor concentrate--United States, September-December 1995.
MedLine Citation:
PMID:  8531917     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Hepatitis A outbreaks associated with receipt of clotting factor concentrate previously have been recognized in Europe but not in the United States (1-5). During September-November 1995, three cases of hepatitis A in recipients of Alphanate factor VIII concentrate (Alpha Therapeutic Corporation, Los Angeles, California) from lot number AP5014A were reported to CDC. On December 8, the manufacturer voluntarily withdrew Alphanate lot number AP5014A from the market. In addition, one case of hepatitis A in a recipient of AlphaNine S-D factor IX concentrate (Alpha Therapeutic Corporation) has been reported and is under investigation. On January 11, 1996, the manufacturer voluntarily withheld four lots of AlphaNine S-D from further distribution as a precautionary measure. This report describes these four cases, summarizes the status of the investigation of the cases, and provides guidelines for testing and reporting of patients who received these products.
Authors:
Related Documents :
12167107 - Autoimmune hepatitis associated with bile duct injury resembling chronic non-suppurativ...
9430027 - Hypogenesis of right hepatic lobe accompanied by portal hypertension: case report and r...
1983827 - Herpes simplex virus hepatitis in pregnancy. two patients successfully treated with acy...
8385167 - Nodular regenerative hyperplasia of the liver in hepatocellular carcinoma. an autopsy s...
2099967 - Successful treatment of an impressive primary lymphedema of the extremities.
16308107 - Fallopian tube prolapse misdiagnosed as vault granulation tissue: a report of three cases.
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  MMWR. Morbidity and mortality weekly report     Volume:  45     ISSN:  0149-2195     ISO Abbreviation:  MMWR Morb. Mortal. Wkly. Rep.     Publication Date:  1996 Jan 
Date Detail:
Created Date:  1996-02-01     Completed Date:  1996-02-01     Revised Date:  2009-11-19    
Medline Journal Info:
Nlm Unique ID:  7802429     Medline TA:  MMWR Morb Mortal Wkly Rep     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  29-32     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Adult
Child
Drug Contamination*
Factor IX / adverse effects,  therapeutic use
Factor VIII / adverse effects,  therapeutic use*
Female
Hemophilia A / drug therapy*
Hepatitis A / epidemiology,  transmission*
Humans
Male
United States / epidemiology
von Willebrand Diseases / drug therapy*
Chemical
Reg. No./Substance:
9001-27-8/Factor VIII; 9001-28-9/Factor IX

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Outbreak of unexplained illness in a middle school--Washington, April 1994.
Next Document:  Deaths associated with Hurricanes Marilyn and Opal--United States, September-October 1995.